Genesis IBRC Intrinsic Value

GENESIS • Healthcare
Current Stock Price
₹91.63
Primary Intrinsic Value
₹18.33
Market Cap
₹119.1 Cr
-80.0% Downside
Median Value
₹18.33
Value Range
₹18 - ₹18
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

GENESIS Valuation Methods Summary

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹18.33 ₹16.50 - ₹20.16 -80.0% Book Value/Share: ₹7.69, P/B: 2.0x
Method Types: Earnings Asset DCF Growth Dividend Conservative

Want to compare with current market value? Check GENESIS share price latest .

Valuation Comparison Chart

GENESIS Intrinsic Value Analysis

What is the intrinsic value of GENESIS?

Based on our comprehensive analysis using 1 different valuation methods, the estimated intrinsic value of Genesis IBRC (GENESIS) is ₹18.33 (median value). With the current market price of ₹91.63, this represents a -80.0% variance from our estimated fair value.

The valuation range spans from ₹18.33 to ₹18.33, indicating ₹18.33 - ₹18.33.

Is GENESIS undervalued or overvalued?

Based on our multi-method analysis, Genesis IBRC (GENESIS) appears to be trading above calculated value by approximately 80.0%.

Financial Health Analysis

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Debt to Equity Ratio 1.20 Industry Standard: <0.5 Above 1.0 Indicates financial leverage level

Cash Flow Quality Analysis

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2018 ₹2 Cr ₹-1 Cr Positive Operating Cash Flow 6/10